ro 19-3704 has been researched along with yohimbine in 1 studies
Studies (ro 19-3704) | Trials (ro 19-3704) | Recent Studies (post-2010) (ro 19-3704) | Studies (yohimbine) | Trials (yohimbine) | Recent Studies (post-2010) (yohimbine) |
---|---|---|---|---|---|
14 | 0 | 0 | 5,893 | 253 | 532 |
Protein | Taxonomy | ro 19-3704 (IC50) | yohimbine (IC50) |
---|---|---|---|
Alpha-2A adrenergic receptor | Homo sapiens (human) | 0.0353 | |
Cytochrome P450 2D6 | Homo sapiens (human) | 1.02 | |
D(2) dopamine receptor | Homo sapiens (human) | 2.06 | |
Alpha-1B adrenergic receptor | Rattus norvegicus (Norway rat) | 1.3 | |
Alpha-2B adrenergic receptor | Homo sapiens (human) | 0.0428 | |
Alpha-2C adrenergic receptor | Homo sapiens (human) | 0.0466 | |
5-hydroxytryptamine receptor 1A | Rattus norvegicus (Norway rat) | 0.126 | |
Alpha-2B adrenergic receptor | Rattus norvegicus (Norway rat) | 0.0682 | |
Alpha-2C adrenergic receptor | Rattus norvegicus (Norway rat) | 0.0682 | |
Alpha-2A adrenergic receptor | Rattus norvegicus (Norway rat) | 0.0682 | |
Alpha-1D adrenergic receptor | Rattus norvegicus (Norway rat) | 1.3 | |
Alpha-1D adrenergic receptor | Homo sapiens (human) | 1.013 | |
5-hydroxytryptamine receptor 1B | Rattus norvegicus (Norway rat) | 0.126 | |
5-hydroxytryptamine receptor 2B | Homo sapiens (human) | 0.074 | |
Alpha-1A adrenergic receptor | Rattus norvegicus (Norway rat) | 1.3 | |
5-hydroxytryptamine receptor 6 | Homo sapiens (human) | 1.689 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fouque, F; Parini, A; Schattner, M; Touqui, L; Vargaftig, BB | 1 |
1 other study(ies) available for ro 19-3704 and yohimbine
Article | Year |
---|---|
Selective inhibition of adrenaline-induced human platelet aggregation by the structurally related Paf antagonist Ro 19-3704.
Topics: 5-Hydroxytryptophan; Binding, Competitive; Diterpenes; Drug Synergism; Epinephrine; Ginkgolides; Glyceryl Ethers; Humans; In Vitro Techniques; Lactones; Morpholines; Platelet Activating Factor; Platelet Aggregation; Platelet Aggregation Inhibitors; Thiazoles; Yohimbine | 1989 |